 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
By harnessing the natural power of the nervous system, Afferent Corporation's revolutionary technology dramatically increases the flow of sensory information traveling from muscles and joints to the body 's control centers. The additional data streaming to the brain and spinal cord drives a remodeling of muscular and nervous systems, producing performance gains that are not otherwise possible. The foundation of his work lies in the well-established interplay between specialized neurons called 'mechanoreceptors' and neuromuscular performance. These sensory neurons, which are found throughout muscles and joints, provide motion and force feedback that is key to all coordinated movement, the acquisition of motor skills, and development of strength. Dr. Collins' important discovery was that small amounts of stimulation applied non-invasively to nearby tissues causes mechanoreceptors to become more sensitive to external stimuli, results that have been published in preeminent scientific journals such as Nature. The Company has the exclusive license to the broad U.S. patents that protect this technology. Jason Harry. Ph.D. and Dr. James Collins, Professor of Biomedical Engineering, founded Afferent. A license agreement is in place between Boston University and Afferent. To date, Afferent has raised over $1.7 million through the sale of equity and from research grant awards. In 2000, $1 million was received in the company's first institutional round of financing from Pharos, LLC. |
|
 |
 |
 |
 |
|
Technology Department | June 13, 2008 | Contact |